Pluristem’s $30 Million Equity Funding Approved by Innovative Medical Management Co.’s Shareholders
Nov 10, 2016 12:01 pm UTC| Business
Term sheet for investment at $1.77 per share is now bindingInnovative Medical is a publicly listed Chinese company active in the healthcare industry, and is an affiliate of ZSVC, one of the largest technology-focused VC...
Nov 10, 2016 12:01 pm UTC| Business
Company reports third quarter revenues of $6.8 Million, an increase of 68% over the third quarter of 2015The revenue growth rate was 58% for the first 9 months of 2016 as compared to 2015Company continues to decrease...
Nov 10, 2016 12:01 pm UTC| Business
Company reports third quarter revenues of $6.8 Million, an increase of 68% over the third quarter of 2015The revenue growth rate was 58% for the first 9 months of 2016 as compared to 2015Company continues to decrease...
Kratos Digital IF Demodulator Selected For U.S. Army Telemetry Modernization Program
Nov 10, 2016 12:01 pm UTC| Business
SAN DIEGO, Nov. 10, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its RT Logic subsidiary was awarded a contract for its Telemetrix...
Kratos Digital IF Demodulator Selected For U.S. Army Telemetry Modernization Program
Nov 10, 2016 12:01 pm UTC| Business
SAN DIEGO, Nov. 10, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that its RT Logic subsidiary was awarded a contract for its Telemetrix...
Merus to Present at the Jefferies London Healthcare Conference
Nov 10, 2016 12:01 pm UTC| Business
UTRECHT, The Netherlands, Nov. 10, 2016 -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, CEO, will...
Merus to Present at the Jefferies London Healthcare Conference
Nov 10, 2016 12:01 pm UTC| Business
UTRECHT, The Netherlands, Nov. 10, 2016 -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton Logtenberg, CEO, will...